Italy vs South Africa: Share of E. coli infections resistant to cephalosporins
Italy
26.5%
in 2022
South Africa
30.0%
in 2022
Italy rank
26th
South Africa rank
24th
Share of E. coli infections resistant to cephalosporins over time
- Italy
- South Africa
How they compare
South Africa currently reports 30.0% against 26.5% in Italy, a difference of 3.5%.
That makes South Africa's figure about 1.1 times Italy's.
The two have swapped places 2 times across 5 shared years of data; in 2018 it was South Africa ahead.
Italy ranks 26th and South Africa ranks 24th of 46 countries.
Across the 2 decades both report, Italy averaged higher in 1 and South Africa in 1.
Head to head by decade
| Decade | Italy | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 31.2% | 30.6% | 0.6% | Italy |
| 2020s | 26.6% | 28.6% | 2.1% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Italy or South Africa?
- South Africa, at 30.0% against 26.5% in Italy as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Italy and South Africa?
- 3.5%, with South Africa ahead.
- How many years of comparable data are there for Italy and South Africa?
- 5 years are reported by both, from 2018 to 2022.
- How do Italy and South Africa rank globally for share of e. coli infections resistant to cephalosporins?
- Italy ranks 26th and South Africa ranks 24th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).